Jindal Speciality Chemicals India Profile
Key Indicators
- Authorised Capital ₹ 9.80 Cr
as on 28-12-2024
- Paid Up Capital ₹ 5.00 Cr
as on 28-12-2024
- Company Age 5 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 148.00 Cr
as on 28-12-2024
- Revenue %
(FY 2022)
- Ebitda
- Net Worth
- Total Assets 408.11%
(FY 2022)
About Jindal Speciality Chemicals India
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 9.80 Cr and a paid-up capital of Rs 5.00 Cr.
The company currently has active open charges totaling ₹148.00 Cr.
Amit Agarwal and Raghav Agrawal serve as directors at the Company.
- CIN/LLPIN
U24100GJ2019PTC111152
- Company No.
111152
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Dec 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Jindal Speciality Chemicals India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Agarwal  | Director | 03-Dec-2019 | Current |
| Raghav Agrawal | Director | 03-Dec-2019 | Current |
Financial Performance of Jindal Speciality Chemicals India.
Jindal Speciality Chemicals India Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Jindal Speciality Chemicals India?
Unlock access to Jindal Speciality Chemicals India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Amitara Green Hi-Tech Park Private LimitedActive 12 years 15 daysAmit Agarwal and Raghav Agrawal are mutual person
Kashyap Tele-Medicines LimitedActive 29 years 10 monthsAmit Agarwal and Raghav Agrawal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 05 Mar 2024 | ₹148.00 Cr | Open |
How Many Employees Work at Jindal Speciality Chemicals India?
Unlock and access historical data on people associated with Jindal Speciality Chemicals India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jindal Speciality Chemicals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jindal Speciality Chemicals India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
